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Comparative transcriptomics of 
multidrug-resistant Acinetobacter 
baumannii in response to antibiotic 
treatments
Hao Qin1,2,6, Norman Wai-Sing Lo3, Jacky Fong-Chuen Loo1, Xiao Lin1,2, Aldrin Kay-Yuen Yim1,2,7, 
Stephen Kwok-Wing Tsui4, Terrence Chi-Kong Lau  5, Margaret Ip3 & Ting-Fung Chan  1,2
Multidrug-resistant Acinetobacter baumannii, a major hospital-acquired pathogen, is a serious health 
threat and poses a great challenge to healthcare providers. Although there have been many genomic 
studies on the evolution and antibiotic resistance of this species, there have been very limited 
transcriptome studies on its responses to antibiotics. We conducted a comparative transcriptomic study 
on 12 strains with different growth rates and antibiotic resistance profiles, including 3 fast-growing 
pan-drug-resistant strains, under separate treatment with 3 antibiotics, namely amikacin, imipenem, 
and meropenem. We performed deep sequencing using a strand-specific RNA-sequencing protocol, 
and used de novo transcriptome assembly to analyze gene expression in the form of polycistronic 
transcripts. Our results indicated that genes associated with transposable elements generally showed 
higher levels of expression under antibiotic-treated conditions, and many of these transposon-
associated genes have previously been linked to drug resistance. Using co-expressed transposon 
genes as markers, we further identified and experimentally validated two novel genes of which 
overexpression conferred significant increases in amikacin resistance. To the best of our knowledge, 
this study represents the first comparative transcriptomic analysis of multidrug-resistant A. baumannii 
under different antibiotic treatments, and revealed a new relationship between transposons and 
antibiotic resistance.
Acinetobacter baumannii is a nosocomial pathogen that can grow in diverse environments, including intensive 
care units. Immunocompromised patients are vulnerable to A. baumannii infection even during therapy. These 
bacteria enter the body through moist tissues and can colonize various sites, such as the respiratory tract, cen-
tral nervous system, skin, and eyes. Pneumonia, blood stream infections, and meningitis are the most frequent 
adverse effects of infection1. The major challenge in the treatment of A. baumannii infection is multidrug resist-
ance. Pan-drug-resistant A. baumannii strains have been reported across Asia and Europe2–4.
Several comparative genomic studies of A. baumannii have discussed the relationships among the variability of 
drug resistance islands and drug-resistant phenotypes2–4. Multidrug-resistant strains possess a higher metabolic 
capacity in environments with limited resources5. Nonetheless, information from genome sequences is not suffi-
cient to capture the dynamics of gene expression. Several transcriptome studies have probed the transcriptional 
changes in the A. baumannii reference strain ATCC17978 when grown under harsh environmental conditions, 
such as ethanol treatment6, high salinity7, and iron deficiency8. These studies particularly noted the strong surviv-
ability of A. baumannii under such conditions. Recent transcriptome studies have also investigated the response 
of this species to antibiotics. For example, a study in which the A. baumannii reference strain ATCC19606 was 
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treated with colistin and doripenem revealed the critical genes involved in the killing process of colistin9, while 
in another study the multidrug-resistant A. baumannii strain MDR-ZJ was treated with tigecycline and identified 
an efflux pump and several transcriptional regulators involved in the drug resistance response10. These studies 
were performed using only single strains, which may limit the generalizability of their conclusions. Due to the 
large variations in genome sizes and sequences among different strains, especially between multidrug-resistant 
and -sensitive ones, a more systematic analysis that is free from strain bias is needed to study and compare their 
transcriptomes under antibiotic-free and -treated environments.
Herein, to better understand the transcriptomic response of drug resistance in A. baumannii, we conducted 
a comparative study of nine multidrug-resistant strains, five of which are pan-drug-resistant, and three sensitive 
strains using a strand-specific RNA-sequencing protocol. We adopted a de novo transcriptome assembly and anal-
ysis pipeline to study gene expression in the form of polycistronic transcripts. Differentially expressed genes were 
analyzed according to the corresponding strain properties. Three multidrug-resistant strains were further treated 
with three antibiotics, namely amikacin, imipenem and meropenem, and the corresponding transcriptomes were 
generated and analyzed. Our results indicated that genes associated with transposable elements in general were 
up-regulated under antibiotic treatment. Many of these genes are known to be drug resistance-related. Among 
several previously unknown transposon-associated genes, we experimentally validated two of them. Expression 
of these two genes in E. coli BL21 conferred increased resistance to amikacin. In summary, we believe our com-
parative transcriptomic study and polycistronic transcript analysis revealed new insights into the drug resistance 
response in A. baumannii. Our analytical approach should also be applicable to similar studies of other bacterial 
pathogens.
Results
A. baumannii strains with different drug resistance profiles exhibited differential growth rates 
in antibiotic-containing media. Twelve strains with different pulsed-field gel electrophoresis (PFGE) pat-
terns (Fig. S1) and antibiotic resistance profiles were collected (Table S1). These include nine multidrug-resistant 
strains (R1 to R9), five of which are pan-drug-resistant (R1, R5, R6, R7, and R8), and three sensitive strains (S1 to 
S3) (Table S1). Seven multidrug-resistant strains (R1 to R7) of the Ia PFGE pattern were clustered to the Global 
Clone II (GC II)4 of multidrug-resistant A. baumannii (Fig. 1a). The other strains belonged to clones other than 
GC I and GC II. Three multidrug-resistant strains (R7, R8, and R9) grew significantly slower than the other nine 
strains after 4 hours (Fig. 1b) based on a pooled two-tailed Student’s t-test (p < 0.01).
De novo transcriptome assembly revealed gene-gene relationships in polycistronic transcripts. 
All 12 strains were cultured in antibiotic-free conditions until mid-log phase. Three multidrug-resistant strains, 
R3, R4, and R5, which are from GC II and show similar PFGE patterns, were also cultured in antibiotic-containing 
media. Three antibiotics, amikacin (an aminoglycoside), imipenem, and meropenem (both of the carbapenem 
class) were chosen, because the 12 strains had exhibited various degrees of resistance to these three antibiotics. In 
total, 18 antibiotic-treated samples were prepared from either mid-log or stationary phases, but only 17 samples, 
excluding the amikacin-treated R4 at mid-log phase, were successfully sequenced. RNA sequencing generated 
a read depth of over 1,000× per sample. A total of 177,939 transcripts were assembled by Trinity11 across 29 
samples. 38.8% of the assembled transcripts could be annotated based on known genes from 15 complete A. bau-
mannii genomes on the transcribing strand, while the other 61.2% of the transcripts could be classified into ERCC 
spike-in sequences, antisense transcripts, or mis-assembled transcripts. Among these annotated transcripts, over 
75% were polycistronic, along which more than one gene could be annotated (Fig. S2). Polycistronic mRNAs 
are produced by prokaryotes to regulate functionally related genes in operons12. In our results, over 97.5% of 
the genes were annotated from at least one polycistronic transcript (Fig. S3a). Genes that were on the same tran-
scripts, particularly those within three loci of one another, had a higher chance of being annotated under the 
same gene ontology (GO) hierarchy (biological process) compared with those that were on different transcripts 
(p < 0.01) (Fig. S3b). Many of these pairs of genes encoded on the same transcript had significantly positive 
Spearman correlations in terms of expression levels. The median Spearman correlation between genes on the 
same transcripts was significantly greater than 0 (p < 0.01) (Fig. S3c).
Amino acid metabolism and membrane transporters were up-regulated in fast-growing pan-drug- 
resistant strains. To investigate the major pathways associated with growth rates, the transcriptomes 
were compared between fast-growing and slow-growing strains at the antibiotic-free mid-log phase. In total, 
133 up-regulated and 53 down-regulated genes were identified in fast-growing strains when compared with 
slow-growing strains. Based on their GO annotations, six GO terms were functionally correlated with the growth 
rate based on Pearson’s chi-square test (q < 0.01) followed by the Benjamini–Hochberg procedure (Fig. 1c). 
Genes that are involved in amino acid metabolic processes and that exhibited the most expression variability 
among multidrug-resistant strains were all significantly up-regulated in fast-growing strains. Contrary to the two 
slow-growing pan-drug-resistant strains R7 and R8, the two fast-growing strains, R5 and R6, exhibited a high 
degree of similarity in expression patterns to the fast-growing, sensitive strains S2 and S3, especially for genes 
involved in amino acid metabolism, glycerol lipid metabolism, siderophore biosynthesis, and transmembrane 
transporters.
Metabolic pathways centered at and around the TCA cycle were consistently up-regulated in all 
three antibiotic treatments. To investigate which genes and pathways were significantly modulated under 
antibiotic treatment, the transcriptomes of the antibiotic-free mid-log phase were compared with those of the 
antibiotic-treated mid-log phase and antibiotic-treated stationary phase from three multidrug-resistant strains 
(R3, R4, and R5). A total of 559 genes were up-regulated and 910 genes were down-regulated in treatment with 
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at least one of the three antibiotics (Fig. S4a). Among them, 172 genes were commonly up-regulated in all three 
antibiotic treatments, with genes involved in metabolism constituting the largest group of these (Fig. 2). Genes 
coding for enzymes involved in the TCA cycle, and in the biosynthesis of some amino acids, purines, and pyri-
midines whose raw materials originate from the TCA cycle, were up-regulated. The complete operons encoding 
enzyme complexes responsible for ATP synthesis, including NADH dehydrogenase, cytochrome C oxidase, and 
ATP synthase, and ribosomal protein operons, were also up-regulated.
Antibiotic-specific responses were also studied. The three A. baumannii strains exhibited distinct responses 
to the two classes of antibiotics (Fig. S4a). Amikacin specifically induced up-regulation of 149 genes, but only 4 
genes were down-regulated. Those up-regulated genes were significantly enriched in unfolded protein binding, 
protein folding, and proteolysis based on a hypergeometric test of enrichment (q-value < 0.01), including two 
protein-folding chaperons (DnaK and HtpX), several peptidyl-prolyl isomerases, and the CLP protease system 
(Fig. 2). In contrast, more than 400 genes were commonly down-regulated when treated with either of the two 
carbapenem-related antibiotics, and only 17 genes were commonly up-regulated. Many transcription factors were 
commonly down-regulated in treatment with imipenem or meropenem. However, up to 60% of the genes that 
were commonly down-regulated in carbapenem do not have any GO-term annotation.
The three strains also exhibited strain-specific responses under different antibiotic treatments (Fig. S4b). Many 
more genes were down-regulated in the pan-drug-resistant strain R5 when compared with R3 and R4. About 24% 
of these R5-specific down-regulated genes were affected by all three antibiotic treatments, of which many were 

























































































































































**  P-value < 0.01
Figure 1. Fast-growing pan-drug-resistant strains exhibited higher nutrition uptake and utilization ability. 
(a) Phylogenetic tree including collected strains and 15 published complete genomes. (b) Growth curves of 12 
strains in BHI broth over 5 hours. Error bars: standard error. p-values were calculated by Student’s t-test.  
(c) Heat map of differentially expressed genes between fast-growing strains and slow-growing strains, classified 
by functional groups.
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Antibiotic resistance genes were expressed in both antibiotic-resistant and -sensitive strains. 
The Comprehensive Antibiotic Resistant Database13 includes a total of 48 known antibiotic resistance-related 
genes that were identified in at least one strain (Fig. 3), which include antibiotic inactivation enzymes, multidrug 
efflux pumps, and direct antibiotic targets. Some of the well-documented resistance-related mutations were also 
identified in the multidrug-resistant strains, such as the two fluoroquinolone-resistance-conferring mutations: 
serine-to-leucine at the 83rd residue in the DNA gyrase subunit A, and serine-to-isoleucine at the 80th residue in 
the DNA topoisomerase IV subunit A14. Moreover, the expression patterns of the drug resistance genes attributed 
to the phenotype of the antibiotic-resistant strains. For example, beta-lactamase which is an enzyme to break 
down the structure of beta-lactam and multidrug efflux pump which transports the antibiotics out of the cell 
(Fig. 3) in particular meropenem were highly expressed in R5 and R6 strains (Table S1) and these two strains were 
resistant to MEM and IPM. Intriguingly, on the other hand, many antibiotic resistance genes were also found to 
be expressed in the sensitive strains (Fig. 3). On this basis, the presence of antibiotic resistance in the resistant 
strains may not be solely due to the expression of one particular antibiotic inactivation enzyme or efflux pump. 
This phenomenon also suggested the combinational and synergic effects of the drug resistance genes expressed 
and functioned with each other in antibiotic resistant bacteria.
Transposon-associated antibiotic resistance genes are major contributors to antibiotic resistance. 
To investigate the driving factors, other than the expression of antibiotic resistance genes, of drug resistance, we 
also examined the extent to which antibiotic resistance genes appeared in polycistronic transcripts. Known anti-
biotic resistance genes were annotated in over 67% of the polycistronic transcripts (Fig. 4a). Over 50% of the other 
co-transcribed genes could be annotated based on their GO terms. These genes are enriched in several functions, 
including amino acid metabolic processes, cell division, and transposition, revealing the complex transcriptional 
regulation of the antibiotic response, with significant q-values as calculated by the Benjamini–Hochberg proce-
dure (q-values < 0.05).
To further identify the genes and pathways that contribute the most to antibiotic resistance, differential gene 
expression analysis was performed between multidrug-resistant and -sensitive strains at the antibiotic-free 
mid-log phase. Four groups of genes that were differentially expressed between multidrug-resistant and -sensitive 































































































































































































AdeR family transcription factors:
G269
AraC family transcription factors:
G1887, G3801, G4432
AsnC family transcription factors:
G1205, G3869
GntR family transcription factors:
G298, G504
Lrp family transcription factors:
G3613
LysR family transcription factors:
G1348, G1558, G2050, G3455, G3782, 
G3805, G4152
MerR family transcription factors:
G1315
MocR family transcription factors:
G284
NikR family transcription factors:
G2879
TetR family transcription factors:
























































































































































































Words & arrows in Red: Consistant up-regulated genes in all three antibiotics treatments
Words & arrows in Purple: Consistant up-regulated genes only in amikacin treatment
Words & arrows in Green: Consistant down-regulated genes in two carbapenems treatment
Words & arrows in Black: Not consistantly dierentially expressed genes 
Figure 2. Genes that were differentially expressed under antibiotic treatment. Red genes or arrows: genes that 
were consistently up-regulated under treatment with all three antibiotics. Purple genes or arrows: genes that 
were consistently up-regulated only under treatment with amikacin. Green genes or arrows: genes that were 
consistently down-regulated only under treatment with the two carbapenem-related antibiotics.
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statistical test (q < 0.01) followed by the Benjamini–Hochberg procedure (Fig. 4b). Responses to antibiotics that 
involve either many known antibiotic resistance genes or DNA-mediated transposons were both up-regulated in 
multidrug-resistant strains.
Some genes can be assembled with an annotated transposable element on the same transcript, and will be 
referred to as “transposon-associated” throughout this study. To globally study the difference in expression 
patterns between transposon-associated genes and non-transposon-associated genes, the cumulative density 
curves of the expressions of both groups of genes were plotted. Gene expressions of three multidrug-resistant 
strains, namely R3, R4, and R5, with or without antibiotic treatment, were pooled according to the conditions 
(antibiotic-free mid-log phase, antibiotic-treated mid-log phase, or antibiotic-treated stationary phase) to be 
analyzed. The expression distributions of transposon-associated genes did not show significant differences from 
non-transposon-associated genes at the mid-log phase under antibiotic-free conditions (Fig. 4c). However, 
transposon-associated genes generally maintained higher expression levels in both mid-log and stationary 
phases under antibiotic treatment, indicated by the significant shift of the curves to the right (higher expression) 
below the 70th percentile based on Wilcoxon’s rank-sum test (p < 0.01) (Fig. 4d,e). This observation also held 
true for individual genes when the cumulative density curves were separately plotted with different antibiotic 
treatments and strains (Fig. S5). To confirm whether antibiotic resistance had a statistically significant correla-
tion with transposon-associated genes by the chi-square test, 39 known drug resistance genes were categorized 
according to their functions, expression patterns, and their co-transcribed genes (Fig. S6a). Transposable ele-
ments showed a higher probability of being co-transcribed with drug inactivation enzymes, and their associ-
ated drug resistance genes were more likely to be up-regulated in multidrug-resistant strains, indicated by the 
significant p-values (p < 0.01). These findings led to the observation that up-regulated drug resistance genes 
were preferentially those coding for drug inactivation enzymes (p = 0.007) (Fig. S6b–d). It was also noticeable 
that all transposon-associated up-regulated drug resistance genes were drug inactivation enzymes (Table S7). 
Furthermore, comparing the expressions of known drug resistance genes between the antibiotic-free mid-log 
phase and the antibiotic-treated mid-log phase of each of the three multidrug-resistant strains (R3, R4, and R5) 
showed that under the antibiotic-treated conditions, transposon-associated resistance genes generally exhibited 
up-regulation compared with antibiotic-free conditions in all three multidrug-resistant strains, with significant 
p-values (p < 0.01) based on the two-tailed Student’s t-test. They also showed greater up-regulation fold changes 
than non-transposon-associated antibiotic resistance genes, with significant p-values in Wilcoxon’s rank-sum test 
Figure 3. Antibiotic resistance genes were widely distributed in resistant and sensitive strains. Each square 
represents the expression level of a gene (across the row) in a given strain (down the column). Genes are grouped 
according to protein functions, followed by the type of antibiotic resistance that the gene is associated with.
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(p < 0.05) (Fig. 4f). However, non-transposon-associated antibiotic resistance genes were not all up-regulated 
under antibiotic treatment. Their expression patterns were found to be strain-specific.
Based on the drug resistance profiles and transcriptome results of the 12 strains collected in this study, and 
combined with the 15 published strains with full genome sequences, several candidate resistance genes were 
identified (Fig. 5). Among these antibiotic-specific resistance genes, beta-lactamase OXA-23 was discov-
ered to be transposon-associated, which was previously reported to confer carbapenem resistance in many 
carbapenem-resistant strains3,4,15–18. In addition, we identified that two transposon-associated genes, namely, 
mph, which codes for the macrolide 2′-phosphotransferase homolog, and mel, which codes for the macrolide 
efflux protein homolog, were assembled onto the same transcript downstream of the transposon gene tnpD in 
all amikacin-resistant strains (R4, R5, R6, R7, and R8), and were also identified in the genomes of A. baumannii 
strains MDR-TJ and TYTH-1 (Fig. 6a). This combination of genes can be identified by BLAST on the plasmids in 
other amikacin-resistant A. baumannii strains, such as BJAB0714 and BJAB0868, and also in other gram-negative 
bacteria, such as Providencia rettgeri, Providencia stuatii, Klebsiella pneumoniae, Klebsiella oxytoca, Citrobacter 
freundii, Salmonella enterica, and Escherichia coli, with nearly full-length coverage at >90% identities. It should 
be noticed that mph and mel may not be the determinants for amikacin resistance as other antibiotic resistance 
genes may have an cooperative effect.
Transposon-associated mph and mel conferred amikacin resistance in E. coli. Reverse-transcription 
PCR (RT-PCR) confirmed that mph and mel were frequently co-transcribed (Fig. 6b), while tnpD and mel were also 
traceably co-transcribed (Fig. S7a). It is noticed that amplicon 1 could not be amplified with RT-PCR, which may 
indicate an assembly error in this contig. This is the disadvantage of transcriptome assembly using short reads19. 
Quantitative PCR further confirmed that mel and mph had similar expression levels (Fig. 6c). To study whether the 
two candidates conferred amikacin resistance, mel, mph and the positive control aacBI, which is known to confer 
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Meropenem treated**: p-value < 0.01
*: p-value < 0.05
Transposon-associated
Non-transposon-associated
Figure 4. Transposons were up-regulated in multidrug-resistant strains and their associated genes maintained 
relatively higher expression in antibiotic-treated environments. (a) Statistics of genes co-transcribed with 
known antibiotic resistance genes. (b) Heat map of differentially expressed genes between multidrug-resistant 
strains and -sensitive strains, classified by functional groups. (c–e) Comparison of percentile-of-expression 
values between transposon-associated genes and non-transposon-associated genes at antibiotic-free mid-log 
phase (c), antibiotic-treated mid-log phase (d), and antibiotic-treated stationary phase (e). Blue line represents 
transposon-associated genes; red line represents non-transposon-associated genes. p-values were calculated by 
Wilcoxon’s rank-sum test. (f) Boxplots of fold changes of known antibiotic resistance genes under the antibiotic 
treatments. Each point represents a log(fold change) value of a known antibiotic resistance gene under a certain 
antibiotic treatment. p-values were calculated by Wilcoxon’s rank-sum test.
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protein expressions were confirmed by western blotting (Fig. S7b). Both mel and mph expression increased the 
resistance of BL21 under amikacin treatment at different concentrations (Fig. 6d). The MIC of the negative control 
was 6 μg/ml, while the aacBI, mel and mph transformed strains had MICs around 16 μg/ml.
Discussion
Comparative genomics studies have been widely conducted to understand the evolution of pathogens toward 
multidrug resistance. However, knowledge of the global regulation of antibiotic resistance genes is still inade-
quate, due to the lack of RNA-seq data and suitable methodologies for comparative transcriptomics. In this study, 
we collected nine multidrug-resistant and three multidrug-sensitive A. baumannii strains, cultured them with 
or without antibiotic treatment, and developed a de novo assembly-based method, by which polycistronic tran-
scripts, the major form of transcription in bacteria, could be reconstructed, to analyze the comparative transcrip-
tomics. This novel method of analysis revealed, for the first time, that the regulation of antibiotic resistance genes 
was performed at the level of operons. Antibiotic resistance genes were systematically analyzed to determine, first, 
with which genes they were co-transcribed, and second, which genes and pathways were significantly modulated 
under treatment with antibiotics.
First, our data suggested that under treatment with both classes of antibiotics, genes in several operons that are 
involved in ATP, RNA, and protein synthesis were simultaneously up-regulated, suggesting that the rates of energy 
and protein production were generally elevated among multidrug-resistant A. baumannii. Many genes involved 
in these pathways were also reported to be up-regulated in Wolbachia under doxycycline treatment22. Moreover, 
the strains also responded differently to the two classes of antibiotics. Amikacin, an aminoglycoside that targets 
the translation machinery, induced up-regulation of over 149 genes, among which were genes involved in protein 
folding and lysis, while only 4 genes were down-regulated. In contrast, the two carbapenem-related antibiotics 
(imipenem and meropenem) led to a general down-regulation of gene expression, including of a large number of 
transcription factors. In addition, most of the imipenem- and meropenem-specific genes encoded either hypo-
thetical proteins or proteins without functional annotation. Thus, there remains a large knowledge gap concern-
ing our understanding of the transcriptional response under carbapenem treatment.
Second, the presence of a single antibiotic resistance gene may not necessarily confer antibiotic resistance in 
A. baumannii. A wide spectrum of antibiotic resistance genes have been identified in all strains, including the 
resistant and sensitive ones (Fig. 3). Some of these genes, e.g. AdeB (G933) (Table S7), a member belonging to the 
AdeABC efflux pump system, have been reported inadequate in development of aminoglycoside resistance23. We 
have shown in this study that expression of mel and mph could confer amikacin resistance, though the MIC of E. 
coli strains expressing AacBI, Mel and Mph under amikacin were around 16 μg/ml, which was lower than the MIC 
of the multidrug-resistant A. baumannii strains (Table S1). Our data suggest that multiple antibiotic resistance 
genes are necessary to confer antibiotic resistance in clinically isolated multidrug-resistant strains.
Third, our data showed that antibiotic resistance genes that were co-transcribed with transposons gener-
ally had higher fold-changes than other resistance genes, which were not associated with transposons, under 
antibiotic treatment and were more likely to confer antibiotic-specific resistance. Both multidrug-resistant 
and -sensitive strains possessed a wealth of antibiotic resistance genes. Most antibiotic resistance genes were 
involved in important operons and were transcribed with other genes. Based on the GO annotations of their 
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Figure 5. Identification of novel antibiotic-specific resistance genes. Each square represents the expression level 
or the presence of a gene (down the column) in a given strain (across the row). The resistance of each strain to 
the three antibiotics is shown on the right panel.
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genes, which are co-transcribed with at least one transposon gene, and non-transposon-associated genes. 
Transposons are among the major players in horizontal gene transfer, which contributes to the evolution of resist-
ance islands in A. baumannii genomes24. It has been reported that the insertion of transposable elements may cre-
ate active promoters and induce high-level expressions of downstream genes25,26. Moreover, our results revealed 
that transposable elements could also shape gene expression patterns under antibiotic treatment. Not all trans-
posable elements and their associated genes were up-regulated under antibiotic treatment (Fig. S8a,b), but they in 
general already have higher fold-changes when compared with non-transposon-associated genes. We found that 
transposon-associated resistance genes had a higher preference to be associated with drug inactivation enzymes, 
which was also reported recently in a comparative genomic study2. Therefore, transposable elements could serve 
as an efficient marker for identifying co-transcribed candidate antibiotic resistance genes, through which two 
novel amikacin resistance genes, namely mel and mph, were reported and experimentally validated in this study. 
Although the relationships between antibiotic treatment and transcription of resistance genes-associated trans-
posons remains unclear, four proteins have been reported as potential regulators involved in transposons expres-
sion27,28. In this study, three of these regulators were identified, including FIS (G2401), H-NS (G3933) and IFH 
(G4261) (Table S8). It would be of interest to investigate relationships between transposons expression and these 
regulators as it could serve as an effective way of reversing drug resistance by inhibiting the transcriptional activ-
ities of transposons.
Materials and Methods
Selection of strains. All strains were isolated from patients at hospitals in Hong Kong (Tables S1 and S2). 
PFGE was performed to identify the strain lineages according to Seifeit et al.29. The PFGE patterns were clus-
tered using the Unweighted Pair Group Method with Arithmetic Mean. Different lineages were determined by a 
similarity cutoff of 80%, with 1.5% position tolerance and 1% band optimization. The minimum inhibitory con-
centrations (MICs) of the antibiotics were determined according to Wiegand et al.30. Multilocus sequence typing 
was performed as described at PubMLST (http://pubmlst.org/abaumannii/). Strains with different lineages or 
antibiotic resistance properties were selected for further study.
Determination of minimum inhibitory concentration (MIC). The MIC of the strains was determined 








































































































































































































Figure 6. Transposon-associated mel and mph were co-transcribed and both contributed to amikacin 
resistance. (a) Transcript structure of the transposon gene with the two candidates. (b) Reverse-transcription 
PCR result of connection regions among three genes (mel, mph, and tnpD). (c) Quantitative PCR results for 
those three genes. (d) Growth of E. coli transformed with the two candidate genes (mel and mph) in different 
amikacin concentrations.
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bacteria were grown in 5% blood agar overnight. Bacterial suspension were prepared to a turbidity equivalent to 
0.5 McFarland. Bacteria were inoculated to the antibiotic-containing Mueller-Hinton agar plates and incubated 
at 37 °C for 16 hours and the MICs were read.
Bacteria culture. A. baumannii was first cultured in BHI broth overnight. 1 ml overnight culture was inoc-
ulated to 100 ml fresh BHI broth. The mid-log (OD600 ~ 1.00) and stationary (OD600 ~ 2.1) samples were har-
vested. The bacteria cultures were incubated at 37 °C with 200 rpm shaking.
To determine the optimal antibiotic concentrations for the antibiotic-treated conditions in LB, 2-fold serial 
dilutions were performed, starting with the MICs as previously determined, to discover the maximum antibiotic 
concentrations at which bacterial growth was not significantly inhibited compared with that in an antibiotic-free 
medium. The final antibiotic concentrations used, in a range from 1/8 to 1/64 of the MICs, are listed in Table S4.
Library preparation and strand-specific RNA-sequencing. Ten to 15 ml of bacteria culture was pel-
leted by centrifugation at 3,500 g for 10 minutes at room temperature. Two to 4 ml of RNAprotect (Qiagen) was 
added to the pellet and mixed by vortexing. The pellet was re-precipitated by centrifugation at 3,500 g for 10 min-
utes at room temperature, and the supernatant was discarded. Standard TRIzol (Life Technologies) protocol was 
then applied to extract total RNAs from the cell pellets. To ensure that the DNA was completely removed, DNase 
digestion was performed and the total RNA samples were further purified by acidic phenol–chloroform. mirVana 
(Life Technologies) was used to deplete tRNAs and other small RNA portions, and the large RNA molecules 
were retained. Ribosomal RNAs were then removed by Ribo-Zero rRNA removal kits for gram-negative bacteria 
(Epicentre). External RNA Controls Consortium (ERCC) RNA Spike-in Control Mixes (Ambion) were added 
to each rRNA-depleted RNA sample according to the user guide. The sequencing libraries were prepared using 
a ScriptSeq v2 RNA-seq Library Preparation kit (Epicentre) with rRNA-depleted samples, and all of the libraries 
were sequenced by Illumina HiSeq 2000 following the strand-specific sequencing protocol for 100 cycles. All 
RNA-seq data have been deposited to SRA with the accession SRP075337.
Reads processing and expression calculation. The first six bases of reads and the adaptors were first 
removed by in-house-developed pipelines. Then, low-quality sequences were trimmed by Trimmomatic 0.3032 
with the following parameters: SLIDINGWINDOW:4:20 and MINLEN:50.
The transcripts were assembled using Trinity r2013-08-1411 with default parameters and specifying–SS_lib_
type as FR. All transcripts were annotated using BLAST based on the 15 full A. baumannii genomes retrieved 
from the NCBI (Table S5), with both coverage and identity larger than or equal to 0.8. Overlapped annotations 
on transcripts were further combined if they overlapped each other by at least 70% of their lengths. Based on 
the gene annotations of the transcripts, the RPKM (reads per kilobase per million mapped reads) values33 were 
calculated to determine the gene expression levels. The expression values were normalized by methods previously 
described34, which can also be found in the supporting documents, under headings Angular based linear regres-
sion, Finding the best regression model and Normalizing samples in different conditions. The expression levels 
of all genes are listed in Table S8.
Differential expression determination. Differentially expressed genes between two phenotypical groups 
of strains (fast-growing vs slow-growing, resistant vs sensitive) were determined by a spatial angular method (refer 
to the Supplementary methods for a detailed description). Differentially expressed genes between antibiotic-free 
conditions and antibiotic-treated conditions were determined by the following set of criteria: (1) to be consid-
ered as an up-regulation under antibiotic treatment, the normalized expression value of the gene in the treated 
sample at mid-log phase must be larger than or equal to 50 RPKM; and to be considered as a down-regulation, 
the normalized expression value of the gene in the untreated sample at mid-log phase must be larger than or 
equal to 50 RPKM; (2) for up-regulation under antibiotic treatment, the normalized expression value of the 
gene in the treated sample at mid-log phase must be at least 2-fold larger than that in the untreated sample; for 
down-regulation under antibiotic treatment, the normalized expression value of the gene in the untreated sample 
at mid-log phase must be at least 2-fold larger than that in the treated sample; (3) finally, for up-regulation under 
antibiotic treatment, according to (2), the normalized expression value of the gene in the treated sample at sta-
tionary phase must be larger than that in the untreated sample at mid-log phase; and for down-regulation, accord-
ing to (2), the normalized expression value of the gene in the untreated sample at mid-log phase must be larger 
than that that in the treated sample at stationary phase. Any gene that was up-regulated in at least two out of three 
strains and at the same time did not show any down-regulation was considered a common up-regulated gene (and 
conversely for the common down-regulated genes). However, because the amikacin-treated R4 sample at mid-log 
phase had failed to be sequenced, only genes up-regulated or down-regulated in both the R3 and R5 strains 
were used to determine common differentially expressed genes for amikacin. For Fig. S5A, the criteria used for 
the amikacin-treated R4 samples were loosened. Genes whose normalized expression values in the untreated 
sample at mid-log phase were smaller than those in the treated sample at stationary phase were considered to be 
up-regulated (likewise, down-regulated genes were considered to be those whose normalized expression values in 
the treated sample at stationary phase were smaller than those in the untreated sample at mid-log phase).
Other bioinformatic analysis. Details of the expression normalization are described in the supporting 
documents, under headings Angular based linear regression, Finding the best regression model and Normalizing 
samples in different conditions. For phylogenetic analysis, genes that were expressed in the antibiotic-free sam-
ples of all strains and could be identified in all 15 of the complete A. baumannii genomes were selected, whereas 
transposon-related genes and common drug resistance genes were excluded. The sequences were aligned sepa-
rately using MUSCLE35 3.8.31 and only the aligned regions were then extracted and concatenated. The phyloge-
netic trees were constructed using the neighbor-joining method in MEGA 636. To annotate GO terms to each 
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gene, BLASTX searches for all of the genes were performed against the nr protein database with default param-
eters, and only the top 50 hits were retained, which were then annotated by Blast2GO37 with default parameters. 
GO enrichment was measured in terms of q-values, calculated based on a hypergeometric distribution and the 
Benjamini–Hochberg procedure. The q-values of the functional correlation of the GOs were determined using a 
chi-square distribution in a contingency table and with the Benjamini–Hochberg procedure.
Validation of differentially expressed genes by quantitative PCR (qPCR). Power SYBR Green PCR 
master mix (Life Technologies) was used according to the standard protocol. A master mix solution was made for 
each sample. Each 20 μl technical replicate contained 5 ng templates, 375 nM primers (Table S6), and 1× power 
SYBR Green PCR master Mix. qPCR was performed using an ABI 7500 fast qPCR machine with 40 thermal 
cycles. Each thermal cycle began with a holding stage at 50 °C for 2 minutes, following by another holding stage at 
95 °C for 10 minutes. Then, the cycling stage started with a denaturing step at 95 °C for 15 seconds, followed by a 
1-minute annealing and elongation step at 60 °C. The top 3 most stably expressed genes at mid-log phase growing 
in both the antibiotic-free and antibiotic-treated media were used separately as reference genes. ATP-dependent 
protease (G707) had the smallest variations between biological replications and fitted the trend of RNA-seq. It was 
therefore chosen as the reference gene in the qPCR validation step.
First-strand cDNA synthesis. The SuperScript III first-strand synthesis SuperMix for qRT-PCR (Life 
Technologies) was used. The reaction mixture was prepared according to the standard protocol. The mixture was 
first incubated at 25 °C for 10 minutes, followed by incubation at 50 °C for 30 minutes. The reaction was termi-
nated at 85 °C for 5 minutes and cooled over ice. 2 U of E. coli RNase H was added to the mixture and incubated 
at 37 °C for 20 minutes.
PCR and Sanger sequencing. A 50-μl reaction mixture was prepared for each PCR reaction, including 
45 μl Platinum PCR SuperMix (Life Technologies) solution, 5 μM primers (Table S6) and 5 ng templates. The 
reaction started with a 2-minute incubation at 94 °C. Twenty cycles were performed with 30 seconds of denatur-
ing at 94 °C, 30 seconds of annealing at 57 °C, and 1 minute/kb extension at 72 °C. The PCR products were purified 
by PureLink Quick Gel Extraction and a PCR purification Combo Kit (Life Technologies) based on the standard 
protocol. The correct sequences of the PCR products were confirmed by Sanger sequencing.
Bacterial transformation. All plasmids were constructed either using a Champion™ pET101 Directional 
TOPO® Expression Kit following the standard protocol, or by a gene synthesis service from GenScript (Nanjing, 
China) on pET15b, which is the closest plasmid to pET101 in the sequence (Table S3). 1 to 10 ng plasmids were 
transformed to BL21 competent cells (Life Technologies) following the standard protocol. Single colonies were 
selected from the LB agar plate with 50 ug/ml ampicillin. The DNA of the plasmids was extracted and the correct 
sequences were confirmed by Sanger sequencing.
Western blot analysis. Bacterial cells were harvested after 4 hours induction in 1 mM IPTG. The OD600 
values were adjusted to 1.0. All samples were lyzed in bacterial lysis buffer (1% SDS in PBS) and loaded onto 12% 
SDS-PAGE for western blot analysis. 1:3000 anti-HIS antibodies (GE 27-4710-01) and 1:2000 anti-FLAG antibod-
ies (Sigma F3165) in 5% fat-free milk were used as primary antibodies to detect the expression of the candidate 
resistance genes, engineered with either an HIS-tag (for AacBI and Mel) or a FLAG-tag (for Mph).
Testing of candidate antibiotic resistance genes. Bacteria transformed with the expression vector 
were incubated at 37 °C in LB at 150 rpm until OD600 was equal to 0.4. 1 mM IPTG was added and the bacte-
ria were incubated for 4 hours to induce protein expression. The culture was diluted to a final OD600 of 0.01. 
Amikacin at the desired concentrations along with 1 mM IPTG were added, and the bacteria were incubated at 
37 °C and 150 rpm. The OD600 values were taken every one hour.
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